Pathogenesis of hereditary tumors: beyond the “two‐hit” hypothesis
- 11 November 2002
- journal article
- review article
- Published by Wiley in Clinical Genetics
- Vol. 62 (5) , 345-357
- https://doi.org/10.1034/j.1399-0004.2002.620501.x
Abstract
Knudson's 'two-hit' hypothesis has provided extremely important insights into the pathogenesis of tumors in autosomal dominant tumor predisposition syndromes, but recent evidence suggests that some such tumors may occur without a 'second hit' or require more than two mutations. Inactivation of both RB1 alleles appears to be insufficient by itself to cause malignancy in the tumors that develop in patients with hereditary retinoblastoma. On the other hand, certain tumors in patients with tuberous sclerosis complex appear to develop in haploinsufficient tissues that do not have 'second hit' mutations of a tuberous sclerosis gene. The molecular pathogenesis of certain other tumors in patients with tuberous sclerosis complex or neurofibromatosis 1 may not be fully explained by the 'two-hit' hypothesis either. Hereditary tumors, like non-hereditary tumors, may arise by a variety of molecular mechanisms, with loss of both alleles of a particular tumor suppressor gene being a frequent, but not invariably necessary or sufficient, event. Four models are presented to explain how various tumors may arise in patients with inherited tumor predisposition syndromes such as hereditary retinoblastoma, tuberous sclerosis complex or neurofibromatosis 1. Even tumors of one particular type may develop by more than one mechanism.Keywords
This publication has 72 references indexed in Scilit:
- CHASING THE CANCER DEMONAnnual Review of Genetics, 2000
- New Function for NF1 Tumor SuppressorJournal of Investigative Dermatology, 2000
- Loss ofNF1 allele in schwann cells but not in fibroblasts derived from an NF1-associated neurofibromaGenes, Chromosomes and Cancer, 1999
- Upregulation of Tumor Suppressor Protein Neurofibromin in Normal Human Wound Healing and In Vitro Evidence for Platelet Derived Growth Factor (PDGF) and Transforming Growth Factor-β1 (TGF-β1) Elicited Increase in Neurofibromin mRNA Steady-State Levels in Dermal FibroblastsJournal of Investigative Dermatology, 1998
- Confirmation of a Double-Hit Model for the NF1Gene in Benign NeurofibromasAmerican Journal of Human Genetics, 1997
- Identification of NF1 mutations in both alleles of a dermal neurofibromaNature Genetics, 1996
- Neurofibromatosis 2: loss of merlin's protective spellCurrent Opinion in Genetics & Development, 1996
- TP53 mutations are frequent in malignant NFI tumorsGenes, Chromosomes and Cancer, 1994
- Mechanisms of loss of heterozygosity in retinoblastomaCytogenetic and Genome Research, 1992
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971